To access this element change to forms mode OFF
Grant Award View - GA184771
Enhancing hepatitis C testing and treatment among people who inject...
GA ID:
GA184771
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
29-Jan-2020
Publish Date:
3-Aug-2021
Category:
Health and Medical Research
Grant Term:
1-Sep-2021 to 31-Aug-2026
Value (AUD):
$1,349,603.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Partnership Projects
Grant Activity:
Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings: the ETHOS III Study
Purpose:
Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.
GO ID:
GO Title:
NHMRC Partnership Projects 2020
Internal Reference ID:
GNT2006282
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA